Celularity (CELU) FCF Margin Growth (1y) (2021 - 2025)
Powered by 
Analysis
Celularity (CELU) FCF Margin Growth (1y) (2021 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.20 Bn | 9.35 Bn | 112.79 Mn | 682.00 |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | 1.20 Mn |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 5,823.00 |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | -189.00 |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | 26,580.00 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -1.30 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 226,818.00 |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 1,141.00 |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 1,854.00 |
| 10 | Celularity | 36.65 Mn | 30.48 Mn | -3.27 Mn | -14,818.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -14,818.00 |
| Sep 30, 2025 | -7,716.00 |
| Jun 30, 2025 | 1,131.00 |
| Mar 31, 2025 | 406.00 |
| Dec 31, 2024 | 6,212.00 |
| Sep 30, 2024 | 21,145.00 |
| Jun 30, 2024 | 35,725.00 |
| Mar 31, 2024 | 36,852.00 |
| Dec 31, 2023 | 69,710.00 |
| Sep 30, 2023 | 73,702.00 |
| Jun 30, 2023 | 61,397.00 |
| Mar 31, 2023 | 20,285.00 |
| Dec 31, 2022 | -2,805.00 |
| Sep 30, 2022 | -61,218.00 |
| Jun 30, 2022 | -38,975.00 |
| Mar 31, 2022 | 39,682.00 |
| Dec 31, 2021 | 10,066.00 |
| Sep 30, 2021 | 102,098.00 |